Abstract
In recent years obesity has emerged as a major threat to the health of mankind. At the same time, advances into appetite regulation and weight control has led to and helped our understanding of the pathophysiology of this complex system. Opinion has therefore changed from consideration of obesity as a self-inflicted problem to a view that it is a complicated disease with an associated increase in morbidity and mortality. In this chapter we review the central nervous system (CNS) neuropeptides which have been implicated as components of the systems regulating body weight.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Akabayashi A, Koenig JI, Watanabe Y, Alexander JT, Leibowitz SF (1994) Galanincontaining neurons in the paraventricular nucleus: a neurochemical marker for fat ingestion and body weight gain. Proc Natl Acad Sci USA 91:10375–10379
Allen JM, Raine AE, Ledingham JG, Bloom SR (1985) Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 68:373–377
Apfelbaum, M, Mandenoff, A (1981) Naltrexone suppresses hyperphagia induced in the rat by a highly palatable diet. Pharmacol Biochem Behav 15:89–91
Arase K, Shargill NS, Bray GA (1989a) Effects of corticotropin releasing factor on genetically obese (fatty) rats. Physiol Behav 45:565–570
Arase K, Shargill NS, Bray GA (1989b) Effects of intraventricular infusion of corticotropin-releasing factor on VMH-lesioned obese rats. Am J Physiol 256:R751–R756
Arase K, York DA, Shimizu H, Shargill N, Bray GA (1988) Effects of corticotropinreleasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol 255:E255–E259
Arjune D, Bodnar RJ (1990) Suppression of nocturnal, palatable and glucoprivic intake in rats by the kappa opioid antagonist, nor-binaltorphamine. Brain Res 534:313–316
Arjune D, Bowen WD, Bodnar RJ (1991) Ingestive behavior following central [D-Ala2, Leu5, Cys6]-enkephalin (DALCE), a short-acting agonist and longacting antagonist at the delta opioid receptor. Pharmacol Biochem Behav 39:429–436
Arjune D, Standifer KM, Pasternak GW, Bodnar RJ (1990) Reduction by central betafunaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res 535:101–109
Barrachina MD, Martinez V, Wang L, Wei JY, Tache Y (1997) Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc Natl Acad Sci USA 94:10455–10460
Barton C, York DA, Bray GA (1996) Opioid receptor subtype control of galanininduced feeding. Peptides 17:237–240
Beck B, Burlet A, Bazin R, Nicolas JP, Burlet C (1992) Early modification of neuropeptide Y but not of neurotensin in the suprachiasmatic nucleus of the obese Zucker rat. Neurosci Lett 136:185–188
Beczkowska IW, Koch JE, Bostock ME, Leibowitz SF, Bodnar RJ (1993) Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats. Brain Res 618:261–270
Beinfeld MC, Palkovits M (1982) Distribution of cholecystokinin (CCK) in the rat lower brain stem nuclei. Brain Res 238:260–265
Bittencourt JC, Presse F, Arias C, Peto C, Vaughan J, Nahon JL, Vale W, Sawchenko PE (1992) The melanin-concentrating hormone system of the rat brain: an immuno- and hybridization histochemical characterization. J Comp Neurol 319:218–245
Bluet Pajot MT, Presse F, Voko Z, Hoeger C, Mounier F, Epelbaum J, Nahon JL (1995) Neuropeptide-E-I antagonizes the action of melanin-concentrating hormone on stress-induced release of adrenocorticotropin in the rat. J Neuroendocrinol 7:297–303
Bultman SJ, Michaud EJ, Woychik RP (1992) Molecular characterization of the mouse agouti locus. Cell 71:1195–1204
Calvo JC, Yusta B, Mora F, Blazquez E (1995) Structural characterization by affinity cross-linking of glucagon-like peptide-l(7-36)amide receptor in rat brain. J Neurochem 64:299–306
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P (1995) Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks [see comments]. Science 269:546–549
Carr KD, Papadouka V (1994) The role of multiple opioid receptors in the potentiation of reward by food restriction. Brain Res 639:253–260
Chhajlani V, Muceniece R, Wikberg JE (1993) Molecular cloning of a novel human melanocortin receptor [published erratum appears in Biochem Biophys Res Commun 1996 Jan 17;218(2):638]. Biochem Biophys Res Commun 195:866–873
Clark JT, Kalra PS, Crowley WR, Kalra SP (1984) Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427–429
Cuello AC (1983) Central distribution of opioid peptides. Br Med Bull 39:11–16
de Caro G, Micossi LG, Venturi F (1979) Drinking behaviour induced by intracerebroventricular administration of enkephalins to rats. Nature 277:51–53
Deutsch JA, Hardy WT (1977) Cholecystokinin produces bait shyness in rats. Nature 266:196
Douglass J, McKinzie AA, Couceyro P (1995) PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J Neurosci 15:2471–2481
Drozdz R, Siegrist W, Baker BI, Chluba de Tapia J, Eberle AN (1995) Melaninconcentrating hormone binding to mouse melanoma cells in vitro. FEBS Lett 359:199–202
Dryden S, Pickavance L, Frankish HM, Williams G (1995) Increased neuropeptide Y secretion in the hypothalamic paraventricular nucleus of obese (fa/fa) Zucker rats. Brain Res 690:185–188
Dumont Y, Fournier A, St PS, Quirion R (1993) Comparative characterization and autoradiographic distribution o neuropeptide Y receptor subtypes in the rat brain. J Neurosci 13:73–86
Eng J (1992) Exendin peptides. Mt Sinai J Med 59:147–149
Erickson JC, Clegg KE, Palmiter RD (1996) Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y Nature 381:415–421
Erickson JC, Hollopeter G, Palmiter RD (1996) Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y Science 274:1704–1707
Fallon JH, Leslie FM (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249:293–336
Fan W, Boston B, Kesterson RA, Hruby VJ, Cone RD (1997) Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385:165–168
Fellmann D, Bugnon C, Risold PY (1987) Unrelated peptide immunoreactivities coexist in neurons of the rat lateral dorsal hypothalamus: human growth hormonereleasing factorl-37-, salmon melanin-concentrating hormone- and alphamelanotropin-like substances. Neurosci Lett 74:275–80
Fong TM, Mao C, MacNeil T, Kalyani R, Smith T, Weinberg D, Tota MR, Van der Ploeg LH (1997) ART (protein product of agouti-related transcript) as an antagonist of MC-3 and MC-4 receptors. Biochem Biophys Res Commun 237:629–631
Gantz I, Konda Y, Tashiro T, Shimoto Y, Miwa H, Munzert G, Watson SJ, DelValle J, Yamada T (1993) Molecular cloning of a novel melanocortin receptor. J Biol Chem 268:8246–8250
Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T (1993) Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem 268:15174–15179
Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL (1996) A receptor subtype involved in neuropeptide-Y-induced food intake. Nature 382:168–171
Gerald C, Walker MW, Vaysse PJ, He C, Branchek TA, Weinshank RL (1995) Expression cloning and pharmacological characterization of a human hippocampal neuropeptide Y/peptide YY Y2 receptor subtype. J Biol Chem 270:26758–26761
Goke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Goke B (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide l-(7-36)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268:19650–19655
Goke R, Larsen PJ, Mikkelsen JD, Sheikh SP (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7:2294–2300
Goldstone AP, Mercer JG, Gunn I, Moar KM, Edwards CM, Rossi M, Howard JK, Rasheed S,Turton MD, Small C, Heath MM, O’Shea D, Steere J, Meeran K, Ghatei MA, Hoggard N, Bloom SR (1997) Leptin interacts with glucagon-like peptide-1 neurons to reduce food intake and body weight in rodents. FEBS Lett 415: 134–138
Gonzalez Y, Fernandez TM, Sanchez FF, del Rio J (1984) Antagonism of diazepaminduced feeding in rats by antisera to opioid peptides. Life Sci 35:1423–1429
Graham M, Shutter JR, Sarmiento U, Sarosi I, Stark KL (1997) Overexpression of Agrt leads to obesity in transgenic mice. Nat Genet 17:273–274
Griffon N, Mignon V, Facchinetti P, Diaz J, Schwartz JC, Sokoloff P (1994) Molecular cloning and characterization of the rat fifth melanocortin receptor. Biochem Biophys Res Commun 200:1007–1014
Grundemar L, Wahlestedt C, Reis DJ (1991) Neuropeptide Y acts at an atypical receptor to evoke cardiovascular depression and to inhibit glutamate responsiveness in the brainstem. J Pharmacol Exp Ther 258:633–638
Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543–546
Hawkins MF, Cubic B, Baumeister AA, Barton C (1992) Microinjection of opioid antagonists into the substantia nigra reduces stress-induced eating in rats. Brain Res 584:261–265
Hebb DO (1949) The organization of behavior. John Wiley & Sons 171-206
Heinrichs SC, Lapsansky J, Behan DP, Chan RK, Sawchenko PE, Lorang M, Ling N, Vale WW, De SE (1996) Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal. Proc Natl Acad Sci USA 93:15475–15480
Hetherinton AW, Ranson SW (1940) Hypothalamic lesions and adiposity in the rat. Anat Record 78:149–172
Hoist JJ, Orskov C, Nielsen OV, Schwartz TW (1987) Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169–174
Holtzman SG (1974) Behavioral effects of separate and combined administration of naloxone and d-amphetamine. J Pharmacol Exp Ther 189:51–60
Horvath TL, Kalra SP, Naftolin F, Leranth C (1995) Morphological evidence for a galanin-opiate interaction in the rat mediobasal hypothalamus. J Neuroendocrinol 7:579–588
Horvath TL, Naftolin F, Leranth C, Sahu A, Kalra SP (1996) Morphological and pharmacological evidence for neuropeptide Y-galanin interaction in the rat hypothalamus. Endocrinology 137:3069–3078
Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F (1997) Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131–141
Inoue T, Inui A, Okita M, Sakatani N, Oya M, Morioka H, Mizuno N, Oimomi M, Baba S (1989) Effect of neuropeptide Y on the hypothalamic-pituitary-adrenal axis in the dog. Life Sci 44:1043–1051
Inui A, Inoue T, Nakajima M, Okita M, Sakatani N, Okimura Y, Chihara K, Baba S (1990) Brain neuropeptide Y in the control of adrenocorticotropic hormone secretion in the dog. Brain Res 510:211–215
Islam AK, Bodnar RJ (1990) Selective opioid receptor antagonist effects upon intake of a high-fat diet in rats. Brain Res 508:293–296
Jhanwar UM, Beck B, Burlet C, Leibowitz SF (1990) Diurnal rhythm of neuropeptide Y-like immunoreactivity in the suprachiasmatic, arcuate and paraventricular nuclei and other hypothalamic sites. Brain Res 536:331–334
Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271:519–532
Kalra SP, Dube MG, Fournier A, Kalra PS (1991) Structure-function analysis of stimulation of food intake by neuropeptide Y: effects of receptor agonists. Physiol Behav 50:5–9
Kalra SP, Kalra PS (1996) Nutritional infertility: the role of the interconnected hypothalamic neuropeptide Y-galanin-opioid network. Front Neuroendocrinol 17:371–401
Kauth T, Metz J (1987) Immunohistochemical localization of glucagon-like peptide 1. Use of poly- and monoclonal antibodies. Histochemistry 86:509–515
Kawauchi H, Kawazoe I,Tsubokawa M, Kishida M, Baker BI (1983) Characterization of melanin-concentrating hormone in chum salmon pituitaries. Nature 305:321–323
Khawaja XZ, Chattopadhyay AK, Green IC (1991) Increased beta-endorphin and dynorphin concentrations in discrete hypothalamic regions of genetically obese (ob/ob) mice. Brain Res 555:164–168
Kim EM, Welch CC, Grace MK, Billington C, Levine AS (1996) Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus. Am J Physiol 270:R1019–R1024
King MG, Kastin AJ, Olson RD, Coy DH (1979) Systemic administration of Met-enkephalin, (D-Ala2)-Met-enkephalin, beta-endorphin, and (D-Ala2)-betaendorphin: effects on eating, drinking and activity measures in rats. Pharmacol Biochem Behav 11:407–411
Koch JE, Bodnar RJ (1993) Involvement of mul and mu2 opioid receptor subtypes in tail-pinch feeding in rats. Physiol Behav 53:603–605
Koch JE, Bodnar RJ (1994) Selective alterations in macronutrient intake of fooddeprived or glucoprivic rats by centrally-administered opioid receptor subtype antagonists in rats. Brain Res 657:191–201
Koob GF, Bloom FE (1985) Corticotropin-releasing factor and behavior. Fed Proc 44:259–263
Kotz CM, Grace MK, Billington CJ, Levine AS (1993) The effect of norbinaltorphimine, beta-funaltrexamine and naltrindole on NPY-induced feeding. Brain Res 631:325–328
Kotz CM, Grace MK, Briggs J, Levine AS, Billington CJ (1995) Effects of opioid antagonists naloxone and naltrexone on neuropeptide Y-induced feeding and brown fat thermogenesis in the rat. Neural site of action. J Clin Invest 96: 163–170
Krahn DD, Gosnell BA, Levine AS, Morley JE (1988) Behavioral effects of corticotropin-releasing factor: localization and characterization of central effects. Brain Res 443:63–69
Kreymann B, Ghatei MA, Burnet P, Williams G, Kanse S, Diani AR, Bloom SR (1989) Characterization of glucagon-like peptide-l-(7-36)amide in the hypothalamus. Brain Res 502:325–331
Kreymann B, Williams G, Ghatei MA, Bloom SR (1987) Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 2:1300–1304
Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S (1998) Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 393:72–76
Kwon HY, Bultman SJ, Loffler C, Chen WJ, Furdon PJ, Powell JG, Usala AL, Wilkiso W, Hansmann I, Woychik RP (1994) Molecular structure and chromosomal mapping of the human homolog of the agouti gene. Proc Natl Acad Sci USA 91:9760–9764
Kyrkouli SE, Stanley, BG, Leibowitz SF (1986) Galanin: stimulation of feeding induced by medial hypothalamic injection of this novel peptide. Eur J Pharmacol 122:159–160
Kyrkouli SE, Stanley BG, Leibowitz SF (1992) Differential effects of galanin and neuropeptide Y on extracellular norepinephrine levels in the paraventricular hypothalamic nucleus of the rat: a microdialysis study. Life Sci 51:203–210
Kyrkouli SE, Stanley BG, Seirafi RD, Leibowitz SF (1990) Stimulation of feeding by galanin: anatomical localization and behavioral specificity of this peptide’s effects in the brain. Peptides 11:995–1001
Lambert PD, Wilding JP, al DA, Bohuon C, Comoy E, Gilbey SG, Bloom SR (1993) A role for neuropeptide-Y, dynorphin, and noradrenaline in the central control of food intake after food deprivation. Endocrinology 133:29–32
Lambert PD, Wilding JP, al DA, Gilbey SG, Bloom SR (1993) The effect of central blockade of kappa-opioid receptors on neuropeptide Y-induced feeding in the rat. Brain Res 629:146–148
Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C (1992) Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Yl type. J Biol Chem 267:10935–10938
Larsen PJ, Tang CM, Hoist J J, Orskov C (1997) Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257–270
Larsen PJ,Tang CM, Jessop DS (1997) Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138:4445–4455
Leibowitz SF, Hor L (1982) Endorphinergic and alpha-noradrenergic systems in the paraventricular nucleus: effects on eating behavior. Peptides 3:421–428
Leibowitz SF, Kim T (1992) Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 599:148–152
Leibowitz SF, Rossakis C (1979) Mapping study of brain dopamine- and epinephrinesensitive sites which cause feeding suppression in the rat. Brain Res 172:101–113
Levine AS, Grace M, Billington CJ (1990) The effect of centrally administered naloxone on deprivation and drug-induced feeding. Pharmacol Biochem Behav 36:409–412
Levine AS, Grace M, Billington CJ, Portoghese PS (1990) Nor-binaltorphimine decreases deprivation and opioid-induced feeding. Brain Res 534:60–64
Lewis LD, Williams JA (1990) Regulation of cholecystokinin secretion by food, hormones, and neural pathways in the rat. Am J Physiol 258:G512–G518
Lu D, Willard D, Patel IR, Kadwell S, Overton L, Kost T, Luther M, Chen W, Woychik RP, Wilkison WO, Cone RD (1994) Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature 371:799–802
Lundberg JM, Terenius L, Hokfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42:167–172
Lundell I, Blomqvist AG, Berglund MM, Schober DA, Johnson D, Statnick MA, Gadski RA, Gehlert DR, Larhammar D (1995) Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY.J Biol Chem 270:29123–29128
Marks KR, Kanarek RB (1980) Morphine selectively influences macronutrient intake in the rat. Pharmacol Biochem Behav 12:427–430
Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD (1998) Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature Medicine 4:718–721
McDonald JK, Lumpkin MD, Samson WK, McCann SM (1985) Neuropeptide Y affects secretion of luteinizing hormone and growth hormone in ovariectomized rats. Proc Natl Acad Sci USA 82:561–564
McKay LD, Kenney NJ, Edens NK, Williams RH, Woods SC (1981) Intracerebroventricular beta-endorphin increases food intake of rats. Life Sci 29:1429–1434
McLaughlin CL, Baile CA, Delia FM (1985) Meal-stimulated increased concentrations of beta-endorphin in the hypothalamus of Zucker obese and lean rats. Physiol Behav 35:891–896
Meeran K, O’Shea D, Turton MD, Heath MM, Gunn I, Choi SJ, Edwards CMB, Small CJ, Ghatei MA, Bloom SR (1996) Chronic blockade of hypothalamic GLP-1 receptors causes obesity. Diabetes 45:170 A
Melander T, Hokfelt T, Rokaeus A (1986) Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 248:475–517
Mercer JG, Hoggard N, Williams LM, Lawrence CB, Hannah LT, Morgan PJ, Trayhurn P (1996) Coexpression of leptin receptor and preproneuropeptide Y mRNA in arcuate nucleus of mouse hypothalamus. J Neuroendocrinol 8:733–735
Mezey E, Kiss JZ, Mueller GP, Eskay R, O’Donohue TL, Palkovits M (1985) Distribution of the pro-opiomelanocortin derived peptides, adrenocorticotrope hormone, alpha-melanocyte-stimulating hormone and beta-endorphin (ACTH, alpha-MSH, beta-END) in the rat hypothalamus. Brain Res 328:341–347
Michel MC, Beck-Sickinger A, Cox H, Doods HN, Herzog H, Larhammar D, Quirion R, Schwartz T, Westfall T (1998) XVI. International union of pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Reviews 50:143–150
Mikkelsen JD, Larsen PJ (1992) A high concentration of NPY (Yl)-receptor mRNAexpressing cells in the rat arcuate nucleus. Neurosci Lett 148:195–198
Miller CL, Hruby VJ, Matsunaga TO, Bickford PC (1993) Alpha-MSH and MCH are functional antagonists in a CNS auditory gating paradigm. Peptides 14:431–440
Miller MW, Duhl DM, Vrieling H, Cordes SP, Ollmann MM, Winkes BM, Barsh GS (1993) Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation. Genes Dev 7:454–467
Miyasaka K, Kanai S, Ohta M, Kawanami T, Kono A, Funakoshi A (1994) Lack of satiety effect of cholecystokinin (CCK) in a new rat model not expressing the CCK-A receptor gene. Neurosci Lett 180:143–146
Morley JE (1987) Neuropeptide regulation of appetite and weight. Endocr Rev 8:256–287
Morley JE, Levine AS (1981) Dynorphin-(l-13) induces spontaneous feeding in rats. Life Sci 29:1901–1903
Morley JE, Levine AS (1982) Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci 31:1459–1464
Mountjoy KG, Mortrud MT, Low MJ, Simerly RB, Cone RD (1994) Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 8:1298–1308
Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992) The cloning of a family of genes that encode the melanocortin receptors. Science 257:1248–1251
O’Shea D, Morgan DG, Meeran K, Edwards CM, Turton MD, Choi SJ, Heath MM, Gunn I, Taylor GM, Howard JK, Bloom CI, Small CJ, Haddo O, Ma JJ, CallinanW, Smith DM, Ghatei MA, Bloom SR (1997) Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology 138:196–202
Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (1997) Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 278:135–138
Panksepp J, Belekedal MYV, Walter M (1996) Potent suppressive effects of the putative satiety agent GLP-1 on social emotive behaviours. Soc Neurosci Abst 22:15.5
Papadouka V, Carr KD (1994) The role of multiple opioid receptors in the maintenance of stimulation-induced feeding. Brain Res 639:42–48
Pedrazzini T, Seydoux J, Konstner P, Aubert J, Grouzmann E, Beermann F, Brunner H (1998) Cardiovascular response, feeding behaviour and locomotor activity in mice lacking the NPY Yl receptor. Nature Medicine 4L722-726
Pernow J, Lundberg JM, Kaijser L (1987) Vasoconstrictor effects in vivo and plasma disappearance rate of neuropeptide Y in man. Life Sci 40:47–54
Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML (1996) Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitarytesticular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 137:3–12
Pinget M, Straus E, Yalow RS (1979) Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex. Life Sci 25:339–342
Potter E, Behan DP, Linton EA, Lowry PJ, Sawchenko PE, Vale WW (1992) The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRE Proc Natl Acad Sci USA 89:4192–4196
Presse F, Nahon JL, Fischer WH, Vale W (1990) Structure of the human melanin concentrating hormone mRNA. Mol Endocrinol 4:632–637
Qu D, Ludwig DS, Gammeltoft S, Piper M, Pelleymounter MA, Cullen MJ, Mathes MF, Przypek J, Kanarek R, Maratos-Filer E (1996) A role for melanin-concentrating hormone in the regulation of feeding behaviour. Nature 380:243–246
Ranee T, Baker BI (1979) The teleost melanin-concentrating hormone - a pituitary hormone of hypothalamic origin. Gen Comp Endocrinol 37:64–73
Reidelberger RD (1992) Abdominal vagal mediation of the satiety effects of exogenous and endogenous cholecystokinin in rats. Am J Physiol 263:R1354–R1358
Ritter RC, Ritter S, Ewart WR, Wingate DL (1989) Capsaicin attenuates hindbrain neuron responses to circulating cholecystokinin. Am J Physiol 257:R1162–R1168
Roane DS, Iadarola MJ, Porter JR (1988) Decreased[3H]-naloxone binding and elevated dynorphin-A(l-8) content in Zucker rat brain. Physiol Behav 43: 371–374
Robbins LS, Nadeau JH, Johnson KR, Kelly MA, Roselli RL, Baack E, Mountjoy KG, Cone RD (1993) Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 72:827–834
Rose C, Vargas F, Facchinetti P, Bourgeat P, Bambal RB, Bishop PB, Chan SM, Moore AN, Ganellin CR, Schwartz JC (1996) Characterization and inhibition of a cholecystokinin-inactivating serine peptidase. Nature 380:403–409
Roselli RL, Mountjoy KG, Robbins LS, Mortrud MT, Low MJ, Tatro JB, Entwistle ML, Simerly RB, Cone RD (1993) Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 90:8856–8860
Rossi M, Small CJ, Goldstone AP, Ghatei MA, Bloom SR (1997a) Melanin concentrating hormone (MCH) concentration is increased in the hypothalamus of obese zucker rats. British Endocrine Society (Abstract)
Rossi M, Choi SJ, O’Shea D, Miyoshi T, Ghatei MA, Bloom SR (1997b) Melanin concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight. Endocrinology 138:351–355
Rossi M, Gunn I, Beak SA, Goldstone AP, Morgan DG, Small CJ, Ghatei MA, Smith DM, Bailey CJ, Bloom SR (1998) Melanin concentrating hormone (MCH) interacts with the leptin system, independently to the melanocortins. European Congress of Endocrinology (Abstract)
Rovere C, Viale A, Nahon J, Kitabgi P (1996) Impaired processing of brain proneurotensin and promelanin-concentrating hormone in obese fat/fat mice. Endocrinology 137:2954–2958
Sagar SM, Sharp FR, Curran T (1988) Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science 240:1328–1331
Saito A, Sankaran H, Goldfine ID, Williams JA (1980) Cholecystokinin receptors in the brain: characterization and distribution. Science 208:1155–1156
Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richarson JA, Kozlowski GP, Wilson S, Arch JR, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu WS, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92:573–585
Sanacora G, Kershaw M, Finkelstein JA, White JD (1990) Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation. Endocrinology 127:730–737
Sanchez M, Baker BI, Celis M (1997) Melanin-concentrating hormone (MCH) antagonizes the effects of alpha-MSH and neuropeptide E-I on grooming and locomotor activities in the rat. Peptides 18:393–396
Schaffhauser AO, Strieker KA, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG (1997) Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides
Schick RR, Harty GJ, Yaksh TL, Go VL (1990) Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: a mapping study. Neuropharmacology 29:109–118
Schick RR, Yaksh TL, Roddy DR, Go VL (1989) Release of hypothalamic cholecystokinin in cats: effects of nutrient and volume loading. Am J Physiol 256:R248–R254
Schwartz MW, Baskin DG, Bukowski TR, Kuijper JL, Foster D, Lasser G, Prunkard DE, Porte D, Woods SC, Seeley RJ, Weigle DS (1996) Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531–535
Scrocchi LA, Brown TJ, MaClusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat Med 2:1254–1258
Sekiya K, Ghatei MA, Lacoumenta S, Burnet PW, Zamir N, Burrin JM, Polak JM, Bloom SR (1988) The distribution of melanin-concentrating hormone-like immunoreactivity in the central nervous system of rat, guinea-pig, pig and man. Neuroscience 25:925–930
Shutter JR, Graham M, Kinsey AC, Scully S, Luthy R, Stark KL (1997) Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Dev 11:593–602
Silvers WK (1979) The coat colors of mice. Springer-Verlag (ed)
Simone DA, Bodnar RJ, Goldman EJ, Pasternak GW (1985) Involvement of opioid receptor subtypes in rat feeding behavior. Life Sci 36:829–833
Skofitsch G, Jacobowitz DM, Zamir N (1985) Immunohistochemical localization of a melanin concentrating hormone-like peptide in the rat brain. Brain Res Bull 15:635–649
Small CJ, Morgan DG, Meeran K, Heath MM, Gunn I, Edwards CM, Gardiner J, Taylor GM, Hurley JD, Rossi M, Goldstone AP, O’Shea D, Smith DM, Ghatei MA, Bloom SR (1997) Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release. Proc Natl Acad Sci USA 94:11686–11691
Smith Al, Funder JW (1988) Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues. Endocr Rev 9:159–179
Smith BK, York DA, Bray GA (1994) Chronic cerebroventricular galanin does not induce sustained hyperphagia or obesity. Peptides 15:1267–1272
Smith GP, Gibbs J (1994) Satiating effect of cholecystokinin. Ann NY Acad Sci 713: 236–241
Spina M Merlo PE, Chan RK, Basso AM, Rivier J, Vale W, Koob GF (1996) Appetitesuppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561–1564
Stanley BG, Kyrkouli SE, Lampert S, Leibowitz SF (1986) Neuropeptide Y chronically injected into the hypothalamus: a powerful neurochemical inducer of hyperphagia and obesity. Peptides 7:1189–1192
Stanley BG, Leibowitz SF (1984) Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 35:2635–2642
Stanley BG, Magdalin W, Seirafi A, Nguyen MM, Leibowitz SF (1992) Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Yl receptor mediating this peptide’s effect. Peptides 13:581–587
Suda T, Tozawa F, Iwai I, Sato Y, Sumitomo T, Nakano Y, Yamada M, Demura H (1993) Neuropeptide Y increases the corticotropin-releasing factor messenger ribonucleic acid level in the rat hypothalamus. Brain Res Mol Brain Res 18:311–315
Tang CM, Larsen PJ, Goke R, Fink JA, Jessop DS, Moller M, Sheikh SP (1996) Central administration of GLP-l-(7-36) amide inhibits food and water intake in rats. Am J Physiol 271:R848–R856
Tatemoto K (1982) Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci USA 79:5485–5489
Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, Mutt V (1983) Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 164:124–128
Tempel DL, Leibowitz KJ, Leibowitz SF (1988) Effects of PVN galanin on macronutrient selection. Peptides 9:309–314
Teskey GC, Kavaliers M, Hirst M (1984) Social conflict activates opioid analgesic and ingestive behaviors in male mice. Life Sci 35:303–315
Thiele TE, Van DG, Campfield LA, Smith FJ, Burn P, Woods SC, Bernstein IL, Seeley RJ (1997) Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats. Am J Physiol 272:R726–R730
Thorens B (1992) Expression cloning of the pancreatic beta cell receptor for the glucoincretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641–8645
Turton MD, Edwards CMB, Meeran K, O’Shea D, Gunn I, Heath MM, Ghatei MA, Bloom SR (1997) Chronic intracerebroventricular administration of GLP-1 reduces body weight in rats. Diabetes 46:185A
Turton MD, O’Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ,Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69–72
Van DG, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ (1996) Central infusions of leptin and GLP-l-(7-36) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 271:R1096–R1100
Varndell IM, Bishop AE, Sikri KL, Uttenthal LO, Bloom SR, Polak JM (1985) Localization of glucagon-like peptide (GLP) immunoreactants in human gut and pancreas using light and electron microscopic immunocytochemistry. J Histochem Cytochem 33:1080–1086
Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C et al (1995) Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287–292
Vaughan JM, Fischer WH, Hoeger C, Rivier J, Vale W (1989) Characterization of melanin-concentrating hormone from rat hypothalamus. Endocrinology 125: 1660–1665
Walker JM, Katz RJ, Akil H (1980) Behavioral effects of dynorphin 1-13 in the mouse and rat: initial observations. Peptides 1:341–345
Weinberg DH, Sirinathsinghji DJ,Tan CP, Shiao LL, Morin N, Rigby MR, Heavens RH, Rapoport DR, Bayne ML, Cascieri MA, Strader CD, Linemeyer DL, MacNeil DJ (1996) Cloning and expression of a novel neuropeptide Y receptor. J Biol Chem 271:16435–16438
Weller A, Smith GP, Gibbs J (1990) Endogenous cholecystokinin reduces feeding in young rats. Science 247:1589–1591
Wilding JP, Gilbey SG, Bailey CJ, Batt RA, Williams G, Ghatei MA, Bloom SR (1993) Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse. Endocrinology 132:1939–1944
Williams G, Gill JS, Lee YC, Cardoso HM, Okpere BE, Bloom SR (1989) Increased neuropeptide Y concentrations in specific hypothalamic regions of streptozocininduced diabetic rats. Diabetes 38:321–327
Wilson BD, Ollmann MM, Kang L, Stoffel M, Bell GI, Barsh GS (1995) Structure and function of ASP, the human homolog of the mouse agouti gene. Hum Mol Genet 4:223–230
Wong G, Pawelek J, Sansone M, Morowitz J (1974) Response of mouse melanoma cells to melanocyte stimulating hormone. Nature 248:351–354
Woychik RP, Generoso WM, Russell LB, Cain KT, Cacheiro NL, Bultman SJ, Selby PB, Dickinson ME, Hogan BL, Rutledge JC (1990) Molecular and genetic characterization of a radiation-induced structural rearrangement in mouse chromosome 2 causing mutations at the limb deformity and agouti loci. Proc Natl Acad Sci USA 87:2588–2592
Yang HY, Panula P, Tang J, Costa E (1983) Characterization and location of Met5-enkephalin-arg6-phe7 stored in various rat brain regions. J Neurochem 40:969–976
Yang YK, Ollmann MM, Wilson BD, Dickinson C, Yamada T, Barsh GS, Gantz I (1997) Effects of recombinant agouti-signaling protein on melanocortin action. Mol Endocrinol 11:274–280
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Rossi, M., Bloom, S.R. (2000). Central Nervous System Neuropeptides Involved in Obesity. In: Lockwood, D.H., Heffner, T.C. (eds) Obesity: Pathology and Therapy. Handbook of Experimental Pharmacology, vol 149. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59651-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-59651-3_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64070-4
Online ISBN: 978-3-642-59651-3
eBook Packages: Springer Book Archive